Market revenue in 2022 | USD 490.9 million |
Market revenue in 2030 | USD 1,013.3 million |
Growth rate | 9.5% (CAGR from 2022 to 2030) |
Largest segment | Consumables & accessories |
Fastest growing segment | Consumables & Accessories |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables & Accessories |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies, PerkinElmer, BD, Danaher Corp, Bio-Rad Laboratories Inc, Biotek, GE HealthCare Technologies Inc Common Stock |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell counting market will help companies and investors design strategic landscapes.
Consumables & accessories was the largest segment with a revenue share of 59.5% in 2022. Horizon Databook has segmented the UK cell counting market based on instruments, consumables & accessories covering the revenue growth of each sub-segment from 2018 to 2030.
The UK is another largest market in Europe for cell counting and is expected to grow at a significant rate owing to increasing focus on drug discovery & development and increasing government funding for new drug development.
Cell counting plays a vital role in the discovery & development of biologics. Thus, the demand for these products is expected to rise in the near future. In addition, escalating demand for personalized medicine in this region is estimated to support market growth.
Personalized medicine is a type of medical therapy in which the treatment is customized for an individual based on the genetic or molecular analysis of the patient. Cell counting techniques can be used in personalized medicines for early detection of disease, selection of appropriate treatment, and determining prognosis of the therapy.
Horizon Databook provides a detailed overview of country-level data and insights on the UK cell counting market, including forecasts for subscribers. This country databook contains high-level insights into UK cell counting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account